Sign Up Today and Learn More About Aprecia Pharmaceuticals Stock
Invest in or calculate the value of your shares in Aprecia Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Aprecia Pharmaceuticals Stock (APPH)
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
About Aprecia Pharmaceuticals Stock
Founded
2003
Headquarters
Langhorne, PA, US
Total Funding
158M
Industries
Software, Artificial Intelligence, Data and Analytics
Aprecia Pharmaceuticals Press Mentions
Stay in the know about the latest news on Aprecia Pharmaceuticals
Three-dimensional printing system and equipment assembly
patents • May 04, 2025
Rapid disperse dosage form
patents • May 04, 2025
Orodispersive dosage forms containing droxidopa
patents • Feb 10, 2025
Functionally-dividable orodispersive dosage form
patents • Feb 10, 2025
Veronica Whitson on LinkedIn: Over the past two years, Dema Alkashkish, Julie Rose Cupka, Sankara…
linkedin • Jun 25, 2024
Aprecia Pharmaceuticals Management
Leadership team at Aprecia Pharmaceuticals
President and Chief Scientist
Donald Monkhouse
Executive Director
Lawrence Glassmann
Join now and verify your accreditation status to gain access to:
- Aprecia Pharmaceuticals Current Valuation
- Aprecia Pharmaceuticals Stock Price
- Aprecia Pharmaceuticals Management
- Available deals in Aprecia Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aprecia Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Aprecia Pharmaceuticals Revenue and Financials
- Aprecia Pharmaceuticals Highlights
- Aprecia Pharmaceuticals Business Model
- Aprecia Pharmaceuticals Risk Factors
- Aprecia Pharmaceuticals Research Report from SACRA Research
Trading Aprecia Pharmaceuticals Stock
How to invest in Aprecia Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Aprecia Pharmaceuticals through EquityZen funds. These investments are made available by existing Aprecia Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aprecia Pharmaceuticals stock?
Shareholders can sell their Aprecia Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
